The National Cancer Institute is offering funding to current NCI P01 program projects for incorporating new NCI-supported technology. This grant encourages applicants to enhance existing research projects by integrating innovative technical approaches or instruments developed through the NCI Innovative Molecular Analysis Technologies (IMAT) program. The aim is to validate and expedite the integration of these technologies into pertinent research fields, fostering collaboration and accelerating progress in cancer research. Deadline for submission is September 29, 2020.
Opportunity ID: 323220
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-20-024 |
| Funding Opportunity Title: | Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.394 — Cancer Detection and Diagnosis Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 20, 2019 |
| Last Updated Date: | Dec 20, 2019 |
| Original Closing Date for Applications: | Sep 29, 2020 |
| Current Closing Date for Applications: | Sep 29, 2020 |
| Archive Date: | Nov 04, 2020 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Special district governments Private institutions of higher education County governments Public housing authorities/Indian housing authorities Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Public and State controlled institutions of higher education State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to encourage revision applications (formerly called “competing revisions”) from currently funded NCI P01 program projects. The applicants should propose to expand upon original research question(s) from specific projects or otherwise accelerate progress for the parent study by incorporating a new technical approach or instrument developed through support from the NCI Innovative Molecular Analysis Technologies (IMAT) program. Awards from this FOA are meant to incentivize independent validation and accelerate the suitability of these emerging technologies for appropriate research communities. As a component of the NCI IMAT program, this FOA aims to promote interdisciplinary collaboration in the development of innovative tools and methods that enable cancer research and accelerate scientific discovery. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-024.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00258979 | Jan 21, 2020 | Sep 29, 2020 | View | |
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00257259 | Jan 21, 2020 | May 24, 2020 | View |
Package 1
Mandatory forms
323220 RR_SF424_2_0-2.0.pdf
323220 PHS398_CoverPageSupplement_5_0-5.0.pdf
323220 RR_OtherProjectInfo_1_4-1.4.pdf
323220 PerformanceSite_2_0-2.0.pdf
323220 RR_KeyPersonExpanded_2_0-2.0.pdf
323220 PHS398_ResearchPlan_4_0-4.0.pdf
323220 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
323220 PHS_Additional_IndirectCosts-1.0.pdf
323220 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
323220 RR_SF424_2_0-2.0.pdf
323220 PHS398_CoverPageSupplement_4_0-4.0.pdf
323220 RR_OtherProjectInfo_1_4-1.4.pdf
323220 PerformanceSite_2_0-2.0.pdf
323220 RR_KeyPersonExpanded_2_0-2.0.pdf
323220 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
323220 PHS_Additional_IndirectCosts-1.0.pdf
323220 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
